Lung Cancer
-
Forward Look
Immunotherapy for Early-stage Lung CancerImmune checkpoint inhibitors can reduce the risk of recurrence for early-stage non-small cell lung cancer, but researchers are still exploring optimal timing for patients who have surgery.
by Anna Napolitano
-
Overcoming Lung Cancer Stigma With UnderstandingShirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.
by Cameron Walker
-
Forward Look
The Lasting Benefit of Immune Checkpoint InhibitorsStudy suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after two years.
by Lindsay Modglin
-
Progress in Lung CancerNovember is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
-
Forward Look
Tissue-sparing SurgeryA clinical trial affirms the value of a procedure that preserves more tissue in early-stage lung cancer patients.
by Ashley P. Taylor
-
Lung Cancer Patients Face Worse Survival After Wildfire ExposureResearchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
by Sandra Gordon
-
Choosing Between Lung Cancer Surgery and RadiationStudy suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
by Jon Kelvey
-
Survivor Profile
The Power of PersistenceAlbert Khoury’s determination to explore all treatment options for his rare lung cancer led to a lifesaving transplant surgery.
by Thomas Celona
-
Forward Look
What’s NextA magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
by Darcy Lewis
-
Facts and Stats
Driving Down Lung Cancer DeathsScreenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
by Eric Fitzsimmons
